138 related articles for article (PubMed ID: 7751472)
21. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.
Vermeer MH; Geelen FA; Kummer JA; Meijer CJ; Willemze R
Am J Pathol; 1999 Apr; 154(4):1203-10. PubMed ID: 10233858
[TBL] [Abstract][Full Text] [Related]
22. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas.
Cerroni L; Volkenandt M; Rieger E; Soyer HP; Kerl H
J Invest Dermatol; 1994 Feb; 102(2):231-5. PubMed ID: 8106752
[TBL] [Abstract][Full Text] [Related]
23. Differential diagnosis of malignant and benign cutaneous lymphoid infiltrates: a study of 57 cases in which malignant lymphoma had been diagnosed or suspected in the skin.
Evans HL; Winkelmann RK; Banks PM
Cancer; 1979 Aug; 44(2):699-717. PubMed ID: 582573
[TBL] [Abstract][Full Text] [Related]
24. Use of polymerase chain reaction in the detection of clones in lymphoproliferative diseases of the skin.
Staib G; Sterry W
Recent Results Cancer Res; 1995; 139():239-47. PubMed ID: 7597295
[TBL] [Abstract][Full Text] [Related]
25. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
26. Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin.
Dereure O; Levi E; Vonderheid EC; Kadin ME
J Invest Dermatol; 2002 Jun; 118(6):949-56. PubMed ID: 12060388
[TBL] [Abstract][Full Text] [Related]
27. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL.
Zoi-Toli O; Vermeer MH; De Vries E; Van Beek P; Meijer CJ; Willemze R
Br J Dermatol; 2000 Aug; 143(2):313-9. PubMed ID: 10951138
[TBL] [Abstract][Full Text] [Related]
28. Lymphomatoid papulosis associated with mycosis fungoides: clinicopathological and molecular studies of 12 cases.
Gallardo F; Costa C; Bellosillo B; Solé F; Estrach T; Servitje O; García-Muret MP; Barranco C; Serrano S; Pujol RM
Acta Derm Venereol; 2004; 84(6):463-8. PubMed ID: 15844638
[TBL] [Abstract][Full Text] [Related]
29. Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin.
de la Garza Bravo MM; Patel KP; Loghavi S; Curry JL; Torres Cabala CA; Cason RC; Gangar P; Prieto VG; Medeiros LJ; Duvic M; Tetzlaff MT
Hum Pathol; 2015 Apr; 46(4):558-69. PubMed ID: 25666664
[TBL] [Abstract][Full Text] [Related]
30. Potential role for microRNA-16 (miR-16) and microRNA-93 (miR-93) in diagnosis and prediction of disease progression in mycosis fungoides in Egyptian patients.
Talaat IM; Abdelmaksoud RE; Guimei M; Agamia NF; Nugud A; El-Serafi AT
PLoS One; 2019; 14(10):e0224305. PubMed ID: 31648231
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
Benner MF; Jansen PM; Meijer CJ; Willemze R
Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
[TBL] [Abstract][Full Text] [Related]
32. Expression of T-cell activation marker CD134 (OX40) in lymphomatoid papulosis.
Gniadecki R; Rossen K
Br J Dermatol; 2003 May; 148(5):885-91. PubMed ID: 12786817
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic Variation in Different Lesions of Mycosis Fungoides Biopsied Within a Short Period of Time From the Same Patient.
Kash N; Massone C; Fink-Puches R; Cerroni L
Am J Dermatopathol; 2016 Jul; 38(7):541-5. PubMed ID: 26885605
[TBL] [Abstract][Full Text] [Related]
34. In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3.
Sommer VH; Clemmensen OJ; Nielsen O; Wasik M; Lovato P; Brender C; Eriksen KW; Woetmann A; Kaestel CG; Nissen MH; Ropke C; Skov S; Ødum N
Leukemia; 2004 Jul; 18(7):1288-95. PubMed ID: 15141228
[TBL] [Abstract][Full Text] [Related]
35. Expression of a Hodgkin and Reed-Sternberg cell associated antigen (Ki-1) in cutaneous lymphoid infiltrates.
Ralfkiaer E; Bosq J; Gatter KC; Schwarting R; Gerdes J; Stein H; Mason DY
Arch Dermatol Res; 1987; 279(5):285-92. PubMed ID: 2820316
[TBL] [Abstract][Full Text] [Related]
36. [Primary cutaneous lymphoma-a case series of 163 patients].
Nashan D; Friedrich CM; Geissler E; Schmitt-Graeff A; Klein F; Meiss F
Hautarzt; 2018 Dec; 69(12):1014-1020. PubMed ID: 29881891
[TBL] [Abstract][Full Text] [Related]
37. Syringotropic mycosis fungoides: a rare variant of the disease with peculiar clinicopathologic features.
Pileri A; Facchetti F; Rütten A; Zumiani G; Boi S; Fink-Puches R; Cerroni L
Am J Surg Pathol; 2011 Jan; 35(1):100-9. PubMed ID: 21164293
[TBL] [Abstract][Full Text] [Related]
38. Multiple cutaneous lymphoproliferative disorders showing a retained tumor clone by T-cell receptor gene rearrangement analysis: a case series of four patients and review of the literature.
Stowman AM; Hsia LL; Kanner WA; Mahadevan MS; Bullock GC; Patterson JW
Int J Dermatol; 2016 Feb; 55(2):e62-71. PubMed ID: 26266670
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response.
Edström DW; Porwit A; Ros AM
Acta Derm Venereol; 2001; 81(3):184-8. PubMed ID: 11558874
[TBL] [Abstract][Full Text] [Related]
40. Unilesional mycosis fungoides: a study of seven cases.
Hodak E; Phenig E; Amichai B; Feinmesser M; Kuten A; Maron L; Sahar D; Bergman R; David M
Dermatology; 2000; 201(4):300-6. PubMed ID: 11146338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
